Universidad de Almeria   Report issue

Academic/Hospital
Founded: Almeria Spain (1993)

Organization Overview

First Clinical Trial
2015
NCT02642289
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Pablo Román López | Universidad de Almeria | Universidad de Almería

Active Ingredients

Drugs in Other Trials (3)

bifidobacterium lactis (1 trial)

chickpea (1 trial)

lactobacillus rhamnosus (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 3